News & Updates

Eccentric and concentric training similarly improve walking distance in severe COVID-19 survivors in the CovExc trial.

A response-tailored strategy decreases antibiotic duration by 2 weeks compared with standard therapy in patients with left-sided infective endocarditis, without compromising their safety. This is the primary result of the POET-II study presented at ESC Congress 2026.

According to an outpatient surveillance study in Hong Kong, minimally invasive nose-only swabs achieved high agreement with joint nose and throat swabs (NTS) for reverse transcription polymerase chain reaction (RT-qPCR) detection of influenza and SARS-CoV-2, thus presenting a viable alternative specimen type for supervised respiratory virus testing.

The week-96 LATA trial results demonstrate the superiority of long-acting injectable (LAI) cabotegravir/rilpivirine (CAB/RPV) to tenofovir/lamivudine/dolutegravir (TLD) for maintaining virologic suppression in adolescents with HIV in sub-Saharan Africa.